CeriBell, Inc. (CBLL) vs Tandem Diabetes Care, Inc. (TNDM)
CeriBell, Inc. and Tandem Diabetes Care, Inc. are both Medical Devices companies. Tandem Diabetes Care, Inc. is the larger, with a market value of $1.1B against $914.2M — 1.2× the size. CeriBell, Inc. grew revenue faster over the last twelve months: 31.7% against 3.96%. Tandem Diabetes Care, Inc. has the higher net margin (−6.08% vs −64.7%) and the higher return on invested capital (−10.3% vs −229.8%). Across the 17 metrics below, Tandem Diabetes Care, Inc. leads on 9 and CeriBell, Inc. on 8.
Valuation
Profitability
| Metric | CBLL | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 88.90% | 56.01% | 56.01% |
| Operating margin | (68.62%) | (4.40%) | (15.03%) |
| Net margin | (64.73%) | (6.08%) | (20.40%) |
| Free cash flow margin | (55.02%) | (2.56%) | (7.24%) |
| Return on equity | (43.93%) | (48.03%) | (15.32%) |
| Return on assets | (35.29%) | (6.24%) | (19.72%) |
| Return on invested capital | (229.76%) | (10.33%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack